Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · Real-Time Price · USD
16.87
-0.17 (-1.00%)
At close: Feb 21, 2025, 4:00 PM
16.94
+0.07 (0.41%)
After-hours: Feb 21, 2025, 6:35 PM EST

Nurix Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Dec - Nov.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2018
Period Ending
Nov '24 Nov '23 Nov '22 Nov '21 Nov '20 2019 - 2018
Net Income
-193.57-143.95-180.36-117.19-43.24
Upgrade
Depreciation & Amortization
15.1312.259.615.282.18
Upgrade
Other Amortization
1.31.41.20.8-
Upgrade
Loss (Gain) From Sale of Assets
0.030.560.010.13-
Upgrade
Loss (Gain) From Sale of Investments
-11.29-5.420.431.710.27
Upgrade
Stock-Based Compensation
33.9333.6728.1315.84.3
Upgrade
Other Operating Activities
0.29-0.2--
Upgrade
Change in Accounts Receivable
--6-6-7.5
Upgrade
Change in Accounts Payable
5.211.610.091.591.23
Upgrade
Change in Unearned Revenue
-28.5519.51-26.6314.2548.18
Upgrade
Change in Income Taxes
---3.64-3.85
Upgrade
Change in Other Net Operating Assets
4.94-1.011.52-4.37-1.66
Upgrade
Operating Cash Flow
-172.58-81.37-159.81-84.37-0.08
Upgrade
Capital Expenditures
-9.27-8.4-12.24-5.66-4.55
Upgrade
Investment in Securities
-248.4476.739.44-102.59-249.85
Upgrade
Investing Cash Flow
-257.7168.327.2-108.25-254.4
Upgrade
Issuance of Common Stock
485.683.2222.43164.13239.42
Upgrade
Repurchase of Common Stock
-0.02----
Upgrade
Other Financing Activities
--94.76-10.24-20.65
Upgrade
Financing Cash Flow
485.673.22117.19153.88339.02
Upgrade
Net Cash Flow
55.37-9.85-15.42-38.7384.54
Upgrade
Free Cash Flow
-181.86-89.77-172.05-90.03-4.63
Upgrade
Free Cash Flow Margin
-333.38%-116.60%-445.42%-302.61%-26.00%
Upgrade
Free Cash Flow Per Share
-2.71-1.65-3.54-2.10-0.30
Upgrade
Cash Income Tax Paid
---0.480
Upgrade
Levered Free Cash Flow
-85.9-41.93-79.42-37.7-25.94
Upgrade
Unlevered Free Cash Flow
-85.9-41.93-79.42-37.7-25.94
Upgrade
Change in Net Working Capital
-6.16-16.06-8.8-19.76-12.75
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.